
TREVISAN ROBERTO
Pubblicazioni
Licini, N., Trevisan, R., Lepore, G., Previdi, F., Ferramosca, A. (2026). Dynamic Target Zone Modulation for Physical Activity Management in Artificial Pancreas Using Pulsatile Zone Model Predictive Control. IEEE TRANSACTIONS ON CONTROL SYSTEMS TECHNOLOGY, 34(4 (July 2026)), 1899-1910 [10.1109/TCST.2026.3676649]. Dettaglio
Mottl, A., Scott, C., Green, J., Heerspink, H., Mann, J., Mcgill, J., et al. (2026). Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 37(4 (April 2026)), 764-776 [10.1681/ASN.0000000928]. Dettaglio
Scalvini, S., Donati, V., Zanelli, E., Giudici, V., Viscardi, L., D'Isa, S., et al. (2026). Phase III maintenance telerehabilitation in elderly patients with chronic heart failure and type 2 diabetes (TELEMECHRON study). EUROPEAN JOURNAL OF INTERNAL MEDICINE [10.1016/j.ejim.2026.106981]. Dettaglio
Beernink, J., Heerspink, H., Birkenfeld, A., Cherney, D., Colhoun, H., Groop, P., et al. (2026). Effect of Finerenone on Albuminuria in Type 1 Diabetes by Baseline HbA1c Level and Diabetes Duration: An Exploratory Analysis of the FINE-ONE Trial. DIABETES CARE, 49(8), 1434-1441 [10.2337/dc26-0882]. Dettaglio
Csermely, A., Borella, N., Turazzini, A., Pilati, M., Sheiban, S., Bonadonna, R., et al. (2026). Different Times for Different Metrics: Predicting 90 Days of Intermittently Scanned Continuous Glucose Monitoring Data in Subjects With Type 1 Diabetes on Multiple Daily Injection Therapy. Findings From a Multicentric Real-World Study. JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY, 20(3 (May 2026)), 761-774 [10.1177/19322968241308564]. Dettaglio